Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Updated final results of the randomized phase II AIO-NEONAX trial - Thomas Jens, E; Waldemar, U; Marko, K (Journal of Clinical Oncology, 2022)
et al.